Marta Amengual‐Gual

758 total citations
20 papers, 319 citations indexed

About

Marta Amengual‐Gual is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Marta Amengual‐Gual has authored 20 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Psychiatry and Mental health, 13 papers in Pediatrics, Perinatology and Child Health and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Marta Amengual‐Gual's work include Epilepsy research and treatment (13 papers), Pharmacological Effects and Toxicity Studies (10 papers) and Neuroscience and Neuropharmacology Research (5 papers). Marta Amengual‐Gual is often cited by papers focused on Epilepsy research and treatment (13 papers), Pharmacological Effects and Toxicity Studies (10 papers) and Neuroscience and Neuropharmacology Research (5 papers). Marta Amengual‐Gual collaborates with scholars based in United States, Spain and Chile. Marta Amengual‐Gual's co-authors include Iván Sánchez Fernández, Tobias Loddenkemper, Mark S. Wainwright, Marina Gaínza‐Lein, Adriana Ulate-Campos, Edward Faught, David G. Vossler, Edward J. Novotny, David Gloss and Dean K. Naritoku and has published in prestigious journals such as PLoS ONE, Brain Research and Epilepsia.

In The Last Decade

Marta Amengual‐Gual

19 papers receiving 313 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marta Amengual‐Gual United States 9 210 122 86 85 29 20 319
Adriana Ulate-Campos Spain 10 243 1.2× 96 0.8× 202 2.3× 71 0.8× 35 1.2× 18 382
Basanagoud Mudigoudar United States 10 192 0.9× 71 0.6× 157 1.8× 53 0.6× 14 0.5× 12 355
Carmela Salladini Italy 12 163 0.8× 99 0.8× 46 0.5× 79 0.9× 19 0.7× 20 303
Alba Sierra‐Marcos Spain 10 137 0.7× 51 0.4× 110 1.3× 40 0.5× 25 0.9× 18 292
Daniel W. Shrey United States 11 127 0.6× 44 0.4× 154 1.8× 49 0.6× 23 0.8× 26 319
Anna Siatouni Greece 13 319 1.5× 201 1.6× 123 1.4× 103 1.2× 12 0.4× 40 588
Pedro Beleza Portugal 8 183 0.9× 66 0.5× 99 1.2× 104 1.2× 9 0.3× 16 291
Annie Bye Australia 10 152 0.7× 157 1.3× 85 1.0× 51 0.6× 7 0.2× 16 335
Mahmoud Mohammadi Iran 11 131 0.6× 64 0.5× 43 0.5× 32 0.4× 17 0.6× 44 326

Countries citing papers authored by Marta Amengual‐Gual

Since Specialization
Citations

This map shows the geographic impact of Marta Amengual‐Gual's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Amengual‐Gual with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Amengual‐Gual more than expected).

Fields of papers citing papers by Marta Amengual‐Gual

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta Amengual‐Gual. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Amengual‐Gual. The network helps show where Marta Amengual‐Gual may publish in the future.

Co-authorship network of co-authors of Marta Amengual‐Gual

This figure shows the co-authorship network connecting the top 25 collaborators of Marta Amengual‐Gual. A scholar is included among the top collaborators of Marta Amengual‐Gual based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta Amengual‐Gual. Marta Amengual‐Gual is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Fernández, Iván Sánchez, Marina Gaínza‐Lein, Marta Amengual‐Gual, et al.. (2023). Evolution of antiseizure medication use and cost in the United States of America 2006–2021. Seizure. 112. 128–138. 5 indexed citations
3.
Fernández, Iván Sánchez, Marta Amengual‐Gual, Tahir Sheikh, et al.. (2023). Temporal trends in the cost and use of first‐line treatments for infantile epileptic spasms syndrome. Epilepsia. 64(3). 630–640. 3 indexed citations
4.
Amengual‐Gual, Marta, et al.. (2022). Challenges for Emergency Medical Services in Status Epilepticus Management. Pediatric Neurology. 138. 5–6. 4 indexed citations
5.
Fernández, Iván Sánchez, Marta Amengual‐Gual, Rinat Jonas, et al.. (2022). Health care resource utilization and costs before and after epilepsy surgery. Seizure. 104. 22–31. 5 indexed citations
6.
Bruno, Elisa, Sebastian Böttcher, Pedro F. Viana, et al.. (2021). Wearable devices for seizure detection: Practical experiences and recommendations from the Wearables for Epilepsy And Research (WEAR) International Study Group. Epilepsia. 62(10). 2307–2321. 23 indexed citations
7.
Fernández, Iván Sánchez, Marta Amengual‐Gual, Marina Gaínza‐Lein, et al.. (2021). Cost‐effectiveness of adrenocorticotropic hormone versus oral steroids for infantile spasms. Epilepsia. 62(2). 347–357. 22 indexed citations
9.
Atrache, Rima El, Eleonora Tamilia, Marta Amengual‐Gual, et al.. (2021). Association between semiologic, autonomic, and electrographic seizure characteristics in children with generalized tonic-clonic seizures. Epilepsy & Behavior. 122. 108228–108228. 6 indexed citations
10.
Vieluf, Solveig, Marta Amengual‐Gual, Bo Zhang, et al.. (2021). Twenty‐four‐hour patterns in electrodermal activity recordings of patients with and without epileptic seizures. Epilepsia. 62(4). 960–972. 31 indexed citations
11.
Fernández, Iván Sánchez, et al.. (2021). Convolutional neural networks to identify malformations of cortical development: A feasibility study. Seizure. 91. 81–90. 4 indexed citations
12.
Vossler, David G., Jacquelyn Bainbridge, Jane Boggs, et al.. (2020). Treatment of Refractory Convulsive Status Epilepticus: A Comprehensive Review by the American Epilepsy Society Treatments Committee. Epiliepsy currents. 20(5). 245–264. 68 indexed citations
13.
Fernández, Iván Sánchez, Edward Yang, Marta Amengual‐Gual, et al.. (2020). Deep learning in rare disease. Detection of tubers in tuberous sclerosis complex. PLoS ONE. 15(4). e0232376–e0232376. 23 indexed citations
14.
Fernández, Iván Sánchez, et al.. (2020). The burden of decisional uncertainty in the treatment of status epilepticus. Epilepsia. 61(10). 2150–2162. 6 indexed citations
15.
Amengual‐Gual, Marta, Iván Sánchez Fernández, Alejandra Vasquez, & Tobias Loddenkemper. (2020). Retrospective observational study on hospital readmission for status epilepticus in the United States over 2016. Epilepsia. 61(7). 1386–1396. 7 indexed citations
16.
Fernández, Iván Sánchez, et al.. (2019). Estimating the cost of status epilepticus admissions in the United States of America using ICD-10 codes. Seizure. 71. 295–303. 17 indexed citations
17.
Amengual‐Gual, Marta, Iván Sánchez Fernández, & Mark S. Wainwright. (2018). Novel drugs and early polypharmacotherapy in status epilepticus. Seizure. 68. 79–88. 32 indexed citations
18.
Amengual‐Gual, Marta, Adriana Ulate-Campos, & Tobias Loddenkemper. (2018). Status epilepticus prevention, ambulatory monitoring, early seizure detection and prediction in at-risk patients. Seizure. 68. 31–37. 25 indexed citations
19.
Amengual‐Gual, Marta, Iván Sánchez Fernández, & Tobias Loddenkemper. (2018). Patterns of epileptic seizure occurrence. Brain Research. 1703. 3–12. 30 indexed citations
20.
Cardo, Esther & Marta Amengual‐Gual. (2015). [Is attention deficit hyperactivity disorder associated with other prevalent pathologies of early childhood?].. PubMed. 60 Suppl 1. S109–13. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026